You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Human Papillomavirus Vaccines: An Update for Gynecologists

AULT, KEVIN A. MD

Clinical Obstetrics & Gynecology:
doi: 10.1097/GRF.0b013e31818092df
New Antibiotics and Vaccines in Obstetric Practice
Abstract

Human papillomavirus (HPV) infections cause several common gynecologic problems. Oncogenic HPV infections are responsible for abnormal cervical cytology, cervical dysplasia, and cervical cancer. In 2006, a vaccine was introduced to prevent these common problems in women's health. The currently available HPV vaccine is quadrivalent, with HPV types 6, 11, 16, and 18. Recently published clinical trials have consistently shown efficacy approaching 100%. Current clinical recommendations are for universal vaccination of adolescent and young adult women. This review will discuss the natural history and epidemiology of HPV, the diseases associated with these infections and current clinical usage of this vaccine. Future developments in this area will also be discussed.

Author Information

Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia

Correspondence: Kevin Ault, MD, Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA 30303. E-mail: kevin.ault@emory.edu

© 2008 Lippincott Williams & Wilkins, Inc.